Finasteride blocks neurosteroids; persistent harm remains debated

Finasteride shuts down 5-alpha-reductase: Persistent harm under scrutiny

A man over 80 takes dutasteride for his prostate and, according to a participant, functions "like clockwork." Another user reports applying topical minoxidil, which delayed hair loss by about three years. Between these two cases lies the entire debate currently occupying those anxiously examining their receding hairlines: finasteride, the drug millions take daily against baldness, inhibits an enzyme—5-alpha-reductase—involved in neurosteroid synthesis. Up to this point, it is standard biochemistry. The question being resolved is whether this inhibition leaves permanent sequelae and how many people are affected.

What exactly does finasteride do in the body?

5-alpha-reductase converts testosterone into dihydrotestosterone (DHT), the hormone that shrinks hair trinc. Blocking it stops hair loss. It also cuts off the pathway producing neurosteroids like allopregnanolone, and that is where the problem begins: the body has no undo button. "Once you remove a gear from a watch, it's hard to put it back," summarizes the starting thesis. The system may remain out of adjustment.

The package insert already lists sensual side effects—reduced libido, erectile dysfunction, decreased ejaculate volume—in a small percentage of users, higher than placebo. In 2012, the FDA added that these effects can persist after stopping treatment, and in 2025, the EMA reviewed the risk of suicidal ideation. Warnings exist. Whether they are read is another matter.

Post-finasteride syndrome: Real cases versus skepticism

Some report loss of sensitivity, spasms, sleep apnea, tachycardia, or cognitive problems that do not remit upon stopping the pill. Against this, the skeptical current responds with the usual argument: "It has been used for 30 years, and only a few on Reddit talk about the mysterious syndrome." They add that most consumers have gone decades without incidents. Therefore, the discussion is not whether the drug works—it does—but how much weight the risk carries on the balance.

Topical does not miccionan harmless

Spray or lotion formats are sold as a mild alternative. Data points to lower systemic absorption than the pill, but not zero: blood DHT levels drop anyway, and with home dosing, peaks can approach those of the oral route. The practical conclusion is uncomfortable: less risk is not no risk.

Minoxidil: The other drug in the equation

Minoxidil is a vasodilator, not a hormonal inhibitor. It relaxes smooth muscle and opens vessels, which theoretically favors erection rather than impeding it. There are isolated cases of dysfunction in forums and some in vitro studies showing reduced 5-alpha-reductase in skin cells, but nothing proving a systemic sensual effect. The difference with finasteride is one of degree and reversibility: according to some participants, here most recover upon discontinuing the product.

The disorienting fact: while health authorities withdraw food products due to trace carcinogens without anyone noticing symptoms, a drug altering a central hormonal pathway is dispatched with a fine-print warning. The question is not whether finasteride is toxic. It is how much we are willing to pay to keep our hair.